abstract |
The present invention describes an immunogenic composition comprising conjugates of S. pneumoniae capsular saccharides of serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, vaccine manufacturing methods and vaccine applications are also described. |